| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Wednesday, April 06, 2022 12:27:09 AM
As soon as theres a sniff of an eua filing, irrespective of how long the fda decision takes, Revive's pps launches.
How high is left to be seen.
And yes, the downward trend in these final stages is totally opposite to what wouldve happen with any other stock in the same position.
How high is left to be seen.
And yes, the downward trend in these final stages is totally opposite to what wouldve happen with any other stock in the same position.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
